Q-Pharm Pty Ltd

Running trials

• Not yet recruiting

  A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.

  NCT07890870· Phase 1· Source

• Recruiting

  A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body

  NCT07649265· Phase 1· Source

• Recruiting

  Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers

  NCT07347678· Phase 1· Source

• Recruiting

  A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants

  NCT07230496· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Familial hypercholesterolaemia1 recruiting
• Lupus (SLE)1 recruiting
• Rheumatoid arthritis1 recruiting
• Sjögren's disease1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women

  NCT05225857· Phase 1· Source